Intravenous dipyridamole-induced myocardial ischemia during percutaneous transluminal coronary angioplasty in humans

Allan L. Klein(Cleveland Clinic), Donald S. Beanlands, Brian C. Morton(University of Ottawa), Jean-François Marquis(Ottawa Heart Institute), Lyall Higginson(University of Ottawa), William L. Williams(University of Ottawa), Ross A. Davies(St. Michael's Hospital)

The American Journal of Cardiology

February 1, 1989

10.1016/0002-9149(89)90311-1

Cited by 5

Related Papers

Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women

|JAMA|2002|576

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

|Circulation|1994|505

High-Dose Epinephrine in Adult Cardiac Arrest

|New England Journal of Medicine|1992|377

Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial

|The Lancet|2001|346

Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation Therapy

|Journal of the American College of Cardiology|2013|272